Prognostic values of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) expression in tissues of diffuse large B-cell non-Hodgkin lymphoma patients - an immunohistochemical study.

Faculty Medicine Year: 2022
Type of Publication: ZU Hosted Pages:
Authors:
Ahmed Shehata Mostafa Embaby
Journal: Contemporary Oncology/Współczesna Onkologia Termedia Publishing House Ltd Volume:
Keywords : Prognostic values , myeloid differentiation factor , (MYD88)    
Abstract:
Introduction: Diffuse large B-cell nonHodgkin lymphoma (DLBCL) is the largest common category of adult lymphoma. Recurrence and treatment resistance occurs in one-third of cases, triggering them to the progressive stage of DLBCL after treatment. Detection of novel predictive and prognostic biomarkers leads to improvement of its treatment and prognosis. Aim of the study: To assess the prognostic roles of protein expression of myeloid differentiation factor 88 (MYD88) and transducin (β)-like receptor 1 (TBLR1) in tissues of DLBCL patients. Material and methods: In the current study we included tissues from 100 cases of DLBCL. For immunohistochemistry, tissues were stained with MYD88 and TBLR1. We followed patients for about 3 years, and then we correlated their expression with clinicopathological and prognostic parameters. Results: Higher MYD88 and TBLR1 expressions were associated with presence of B symptoms, fever, night sweat, advanced stage, bone marrow involvement and bulky nodal size, presence of extra-nodal extension, unfavourable relapse-free survival, and unfavourable overall survival rates (p < 0.001). Conclusions: overexpression of MYD88 and TBLR1 expression was present in DLBCL patients and was associated with unfavourable clinicopathological and prognostic parameters
    
     
 
       

Author Related Publications

  • Ahmed Shehata Mostafa Embaby, "Impact of Immunochemotherapy-Related Hepatic Toxicity on the Outcome of HCV-Positive Diffuse Large B-Cell Lymphoma Patients", Hindawi Publishing Corporation, 2014 More
  • Ahmed Shehata Mostafa Embaby, "Prognostic significance of lymphocyte-to-monocyte ratio in patients with classical Hodgkin lymphoma before and after receiving first-line chemotherapy", Termedia Publishing House Ltd, 2022 More
  • Ahmed Shehata Mostafa Embaby, "Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation", springer one, 2020 More
  • Ahmed Shehata Mostafa Embaby, "Use of prophylactic closed-incision negative-pressure therapy (CINPT) is associated with reduced surgical-site infections in patients undergoing open abdominal surgeries during the Covid-19 pandemic", Medknow, 2021 More
  • Ahmed Shehata Mostafa Embaby, "Predictive Factors of Para-Aortic Lymph Nodes Metastasis and Survival Advantages of Para-Aortic Lymphadenectomy in Early Stage Cervical Cancer", Mary Ann Liebert, Inc., publishers, 2021 More

Department Related Publications

  • Mohamed El Sayed Mohammed Mustafa, "Prevalence of Catheter Related Central Vein Stenosis in Hemodialysis Patients (two centers study)", International Journal of Advanced Research (2014), Volume 2, Issue 11, 1005-1011, 2014 More
  • Mohamed Essam El Din Ahmd, "Does Resistin Gene Polymorphisms +299 (G>A) Participate in Insulin Resistance in Egyptian Non-obese Type 2 Diabetes?", International Journal of Genomic Medicine 2014,vol.2. Issue,1.1000117, 2104 More
  • Ahmed Ibrahim Ibrahim Elagroudy, "Interleukin 28 B Gene Polymorphisms as a Predictor of Treatment Response in Egyptians with Chronic Hepatitis C", Zagazig University Medical Journal, 2014 More
  • Munkez Mutee Yusuf Muhamed, "علاقة الارتداد المعدى بالمرى وارتشاح الاذن الوسطى", لايوجد, 1900 More
  • Khaled Abdelnaby Khodary Mohamed Elhefnawy, "الاديبونيكتين في المصل كدلالة بيولوجية مبكرة لنشاط مرض الذئبة الحمراء والتهاب الكلى Serum Adiponectin as an Early Biomarker of Systemic Lupus Erythematosus activity and lupus nephritis.", Japan International cultural Exchange foundation, 2020 More
Tweet